STOCKS / Finance

Array Biopharma Recoups Some Of Its Losses From Sharply Lower Open

From Technicals
March 20, 2017 - 12:02pm
Array Biopharma Inc (NASDAQ: ARRY) shares are trading lower by $0.66 (7.2 percent) at $9.90 in Monday's session. Before the open, the company announced its new drug application for its Binimetinib Monotherapy for the treatment of a rare skin cancer has been withdrawn from the FDA Division ...Full story available on Benzinga.com


Continue reading this article »